Thought Leadership from our Consultants

At Advanced Clinical, we create industry thought leadership, driving new talent management, a new kind of CRO (strategic sourcing), consulting and technology standards. The AC team and our consultants deliver methods and assets that effect industry leading performance and insight, not only addressing current needs, but predicting future needs as well as setting a standard for excellence.

Advanced Clinical goes beyond claims such as fast, efficient and better to effectively bring drugs to market. We apply our leading practice capabilities to optimize results for our clients. By doing so, we leave them with superior and more streamlined processes, tools and techniques to enable sustainable efficiencies.

Areas of thought leadership include:

• Industry Leading R&D Performance (ILRDP) Method – The diagnostic framework that allows us to assess how to improve the capabilities of the “business of R&D.” The ILRDP method underlies all of our consulting, strategic sourcing, talent management and technology services. We help clients create a step change improvement in their ability to deliver lowest total cost of ownership (TCO), highest probability of success and highest quality, ensuring safety and efficacy
• Strategic Sourcing Solutions – We believe the best sourcing solution strategically combines the best elements of a pure staffing solution and a CRO. We use our “Hybrid-Strategic Sourcing” model to collaboratively plan and efficiently carry out a clinical trial with the right resources
• True Project Management – With experience spanning over 220 clinical trials, we have codified templates and tools for running unparalleled project management. We utilize our Program Management Office approach and our broad project and clinical trial management expertise to deliver optimal results to clients
• Business Case Modeling – We take a game changing approach to our business case model design. We look at the total cost of ownership and the value created (clinical trial acceleration, highest safety, efficacy, comparative effectiveness, highest probability of success) to impact operating income for our clients